- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Blue chip stocks
U.S. Pharmaceuticals & Biotech Blue chip stocks
Results
19
1 new
19 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ILMN | US$136.22 | -0.3% | -3.1% | US$21.4b | US$161.92 | PS4.9x | E54.8% | 2.3% | ||
VRTX | US$439.62 | 4.2% | 2.2% | US$113.2b | US$489.84 | PS10.7x | E36.7% | n/a | ||
NTRA | US$167.61 | 5.8% | 156.1% | US$22.7b | US$178.09 | PS14.4x | E55.6% | n/a | ||
ALNY | US$278.76 | 13.2% | 55.2% | US$35.5b | US$299.71 | PS17.2x | E56.7% | n/a | ||
SRPT | US$116.46 | -1.3% | -1.9% | US$11.4b | US$184.43 | PE91.3x | E31.7% | n/a | ||
EXAS New | US$55.98 | 8.2% | -12.9% | US$10.2b | US$72.19 | PS3.8x | E57.5% | n/a | ||
TECH | US$77.05 | 1.6% | 6.1% | US$12.2b | US$85.26 | PE81.2x | E21.1% | 0.4% | ||
ONC | US$222.08 | 5.7% | 37.2% | US$23.7b | US$283.39 | PS7.3x | E64.7% | n/a | ||
ITCI | US$127.35 | 0.9% | 89.0% | US$13.5b | US$123.55 | PS22x | E52.2% | n/a | ||
QGEN | US$45.63 | -0.8% | 0.4% | US$10.2b | US$51.14 | PE109.1x | E34.4% | 2.8% | ||
VTRS | US$11.20 | -0.9% | -6.1% | US$13.3b | US$13.45 | PS0.9x | E51.6% | 4.3% | ||
ABBV | US$170.30 | -0.7% | 3.6% | US$301.6b | US$199.97 | PE59.2x | E24.1% | 3.9% | ||
BMRN | US$61.73 | 0.3% | -32.1% | US$11.9b | US$97.16 | PE36.5x | E24.1% | n/a | ||
MEDP | US$344.07 | 2.0% | 15.4% | US$10.8b | US$343.03 | PE29.2x | E11.2% | n/a | ||
BMY | US$59.67 | 6.0% | 20.1% | US$119.9b | US$61.01 | PS2.6x | E39.3% | 4.2% | ||
INCY | US$72.59 | 0.9% | 19.7% | US$14.0b | US$79.76 | PE430.5x | E34.1% | n/a | ||
NBIX | US$148.73 | 3.8% | 4.6% | US$14.9b | US$167.59 | PE39x | E26.3% | n/a | ||
LLY | US$785.41 | 8.2% | 22.9% | US$690.3b | US$978.39 | PE84.5x | E24.8% | 0.8% | ||
GILD | US$93.07 | 1.3% | 17.0% | US$115.8b | US$100.00 | PE920.6x | E31.1% | 3.3% |
Page 1 of 1